Status | Study |
RECRUITING |
Study Name: Effect of Amifampridine on Neuromuscular Transmission in Patients Treated With OnabotulinumtoxinA Condition: Botulism Date: 2023-03-03 Interventions: a single dose of amifampridine (20mg) will be orally administered |
Active, not recruiting |
Study Name: Evaluation of the Improvement of Quality of Life of Patients Suffering From Hailey Hailey or Darier Disease After Injections of Botulism Toxin Into Large Folds. Condition: Hailey-Hailey Disease Darier Disease Date: 2016-05-20 Interventions: Drug: Botulism Toxin Treatment Injection of 50 UI of botulism toxin for treated zone |
Active, not recruiting |
Study Name: Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632 Condition: Botulism Date: 2016-05-12 Interventions: Biological: NTM-1632 Monoclona |
Enrolling by invitation |
Study Name: BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients Condition: Botulism Date: 2014-01-29 Interventions: Biological: One 5 mL of blood will be collected. The blood sample should be collected no later than 24 h |
Enrolling by invitation |
Study Name: BT-010 Registry for the Evaluation of Safety and Clinical Outcomes in Patients Treated With Botulinum Antitoxin Condition: Botulism Date: 2014-01-29 |
Suspended |
Study Name: Phase 3, Randomized, Safety, Lot Consistency and Clinical Benefit Study of Recombinant Botulinum Vaccine A/B Condition: Botulism Date: 2013-09-06 Interventions: Biological: rBV A/B 0.5 mL dos |
Completed |
Study Name: Safety, Tolerability, and Immunogenicity Study of Investigational Recombinant Botulinum Vaccine A/B (rBV A/B) in Volunteers Previously Immunized With Investigational Pentavalent Botulinum Toxoid Condition: Botulism Date: 2012-10-03 Interventions: Biological: rBV A/B rBV A/B injections will consist of a single 40 µg injection of total antigen (2 |
Completed |
Study Name: Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of Botulism Condition: Botulism Date: 2011-09-26 Interventions: Drug: 3,4-diaminopyridine test dose 10 mg then 20 mg, then depending on tolerance and efficacy full-dose |
Completed |
Study Name: Phase 1 PK Study of XOMA 3AB Condition: Botulism Date: 2011-05-05 Interventions: Drug: XOMA 3AB Single intraven |
Terminated |
Study Name: Botulism Toxin Injection as a Treatment for Arthritis of the Basal Thumb Joint Condition: Arthritis Multiple Joint Date: 2010-01-07 Interventions: Drug: Botulinum Toxin Type A O |